UnitedHealth Group Inc

UnitedHealth Group Inc(UNH)股票分析

$392.950

-2.083 (-0.53%)收盘时

Loading chart…
High
396.740
Open
396.420
VWAP
394.12
Vol
2.46M
Mkt Cap
447.71B
Low
392.660
Amount
968.40M
EV/EBITDA, TTM
10.78

UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.

AI analysis of UnitedHealth Group Inc (UNH)

hold

UnitedHealth Group Inc is currently a hold. The stock is priced at $392.95, with a forward P/E ratio of 20.24, which is relatively high compared to sector averages, indicating potential overvaluation risks. Despite a solid year-to-date change of +16.81% and a 1-year change of +27.25%, the recent downgrade by Erste Group highlights concerns about low revenue growth expectations for 2026 and 2027. Additionally, insider selling has surged by 2854.33%, signaling potential caution among insiders. The main risk is the high medical care ratio of 86.7%, which pressures profit margins.

Analyst Ratings (22)

+1.24% upside
Buy
22 Buy
0 Hold
0 Sell
Current: 392.95
最低
330.00
平均
397.82
最高
444.00

Erste Group

2026-08-27

目标价

Hold

Mizuho

2026-07-21

目标价

$493

Outperform

Wells Fargo

2026-07-20

目标价

$526

Overweight

Barclays

2026-07-20

目标价

$441

Overweight

BofA

2026-07-17

目标价

$512

Buy

估值指标

The current forward P/E ratio for UnitedHealth Group Inc (UNH) is 20.24, compared to its 5-year average forward P/E of 20.72.

Forward P/E

Fair
5Y Average P/E
20.72
Current P/E
20.24
高估
23.96
低估
17.48

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
14.67
Current EV/EBITDA
10.78
高估
20.03
低估
9.31

Forward P/S

Undervalued
5Y Average P/S
1.11
Current P/S
0.77
高估
1.40
低估
0.81

Alphio AI Price Scenarios for UNH

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%UNH

$396.89

情景价格

B

Base

Base · 50%UNH

$339.20

情景价格

B

Bear

Bear · 25%UNH

$315.88

情景价格

Whales holding UNH

T

Turtle Creek Management, LLC

+ HoldingUNH

+18.57%

3M Return

R

Rock Springs Capital Management LP

+ HoldingUNH

+18.51%

3M Return

I

Integral Health Asset Management, LLC

+ HoldingUNH

+15.08%

3M Return

A

Armistice Capital LLC

+ HoldingUNH

+13.92%

3M Return

S

Smead Capital Management, Inc.

+ HoldingUNH

+9.72%

3M Return

C

Chickasaw Capital Management, LLC

+ HoldingUNH

+9.66%

3M Return

UNH FAQ — answered by Alphio AI

UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).

UnitedHealth Group Inc is currently a hold. The stock is priced at $392.95, with a forward P/E ratio of 20.24, which is relatively high compared to sector averages, indicating potential overvaluation risks. Despite a solid year-to-date change of +16.81% and a 1-year change of +27.25%, the recent downgrade by Erste Group highlights concerns about low revenue growth expectations for 2026 and 2027. Additionally, insider selling has surged by 2854.33%, signaling potential caution among insiders. The main risk is the high medical care ratio of 86.7%, which pressures profit margins.

22 analysts cover UNH: 22 rate it Buy, 0 Hold and 0 Sell. The average price target is 397.82.

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始